The Medical Advisor

If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...

Abstract Methylene blue (MB), a phenothiazine-derived compound with a well-established history in medical applications, has recently garnered attention for its potential role in cancer therapy. This review examines the pharmacological properties, mechanisms of action, and emerging evidence supporting MB's anticancer effects. Through its redox-cycling capabilities, MB influences mitochondrial function, induces oxidative stress in malignant cells, and exhibits selective cytotoxicity. We further explore preclinical and clinical studies evaluating MB's efficacy and safety, while also discussing challenges and future research directions. Introduction Cancer remains a leading cause of morbidity and mortality worldwide, necessitating novel therapeutic approaches. Methylene blue, a heterocyclic aromatic dye initially introduced as an antimalarial agent, has demonstrated various pharmacological activities, including antimicrobial, neuroprotective, and antioxidant properties. Recently, M...

What Is Methylene Blue?  Methylene blue is the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs commonly used to treat not only malaria but also COVID-19. Best known as a fish tank antiseptic and textile dye for blue jeans, it was actually the first synthetic drug in modern history, developed in 1876. Since then, we’ve discovered it has many really important medicinal benefits. The first medical application of methylene blue was for malaria. In 1890, Paul Ehrlich, a scientist at the famous Charité Hospital in Berlin, Germany, discovered methylene blue inhibits an enzyme that weakens the malaria parasite. One of the first antipsychotic medications was also made from methylene blue. Other drugs developed from or with it include antibiotics and antiseptics. In the past, it was commonly used to treat urinary tract infections. It’s also been used as an antiviral agent in blood used for transfusions. To this day, methylene blue is found in every hospital in the wo...